Healthcare provider profile · identity verified

Gregory Greene, DO

Internal Medicine · WESTLAKE, OH · NPI 1518387174

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	755	239
Losartan Potassium	Losartan Potassium	353	104
Amlodipine Besylate	Amlodipine Besylate	349	105
Levothyroxine Sodium	Levothyroxine Sodium	347	94
Gabapentin	Gabapentin	265	67
Simvastatin	Simvastatin	264	73
Lisinopril	Lisinopril	256	85
Omeprazole	Omeprazole	213	68
Hydrochlorothiazide	Hydrochlorothiazide	210	65
Pantoprazole Sodium	Pantoprazole Sodium	207	61
Tamsulosin Hcl	Tamsulosin Hcl	190	57
Metoprolol Succinate	Metoprolol Succinate	185	65
Metformin Hcl	Metformin Hcl	177	50
Metoprolol Tartrate	Metoprolol Tartrate	148	41
Rosuvastatin Calcium	Rosuvastatin Calcium	148	47
Sertraline Hcl	Sertraline Hcl	143	32
Famotidine	Famotidine	142	40
Atenolol	Atenolol	138	45
Eliquis	Apixaban	136	36
Trazodone Hcl	Trazodone Hcl	124	36
Carvedilol	Carvedilol	113	26
Escitalopram Oxalate	Escitalopram Oxalate	107	32
Furosemide	Furosemide	99	26
Albuterol Sulfate Hfa	Albuterol Sulfate	97	49
Pravastatin Sodium	Pravastatin Sodium	92	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	21
Allopurinol	Allopurinol	89	25
Glimepiride	Glimepiride	88	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	26
Fluticasone Propionate	Fluticasone Propionate	80	47
Metformin Hcl Er	Metformin Hcl	78	24
Tramadol Hcl	Tramadol Hcl	77	24
Doxycycline Hyclate	Doxycycline Hyclate	75	64
Mirtazapine	Mirtazapine	74	22
Prednisone	Prednisone	70	54
Duloxetine Hcl	Duloxetine Hcl	67	19
Finasteride	Finasteride	67	20
Bupropion Xl	Bupropion Hcl	62	23
Clopidogrel	Clopidogrel Bisulfate	61	16
Synthroid	Levothyroxine Sodium	59	19
Meloxicam	Meloxicam	58	22
Jardiance	Empagliflozin	57	17
Azelastine Hcl	Azelastine Hcl	55	12
Citalopram Hbr	Citalopram Hydrobromide	54	14
Potassium Chloride	Potassium Chloride	53	18
Buspirone Hcl	Buspirone Hcl	52	13
Fenofibrate	Fenofibrate	52	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	43
Methylprednisolone	Methylprednisolone	50	41
Ozempic	Semaglutide	49	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	48	11
Alprazolam	Alprazolam	47	14
Triamcinolone Acetonide	Triamcinolone Acetonide	45	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Donepezil Hcl	Donepezil Hcl	43	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Naproxen	Naproxen	39	12
Montelukast Sodium	Montelukast Sodium	38	13
Amoxicillin	Amoxicillin	36	24
Mounjaro	Tirzepatide	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	23
Azithromycin	Azithromycin	33	27
Nystatin	Nystatin	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	12
Hydroxyzine Hcl	Hydroxyzine Hcl	31	12
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Lorazepam	Lorazepam	27	11
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Carbamazepine	Carbamazepine	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Mupirocin	Mupirocin	24	15
Ondansetron Odt	Ondansetron	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Glipizide	Glipizide	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Ketoconazole	Ketoconazole	22	11
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Temazepam	Temazepam	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Digoxin	Digoxin	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Estradiol	Estradiol	18	suppressed
Topiramate	Topiramate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Ramipril	Ramipril	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Cephalexin	Cephalexin	16	14
Meclizine Hcl	Meclizine Hcl	16	11
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Primidone	Primidone	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methimazole	Methimazole	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Diazepam	Diazepam	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Baclofen	Baclofen	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error